aTyr Pharma Announces Research Collaboration on ATYR2810
The collaboration will involve preclinical studies of aTyr’s anti-NRP2 antibody ATYR2810 in pediatric osteosarcoma.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.